STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Dostępny od:

Sanofi-Aventis Australia Pty Ltd

INN (International Nazwa):

prochlorperazine mesilate

Forma farmaceutyczna:

Injection

Skład:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Droga podania:

Intramuscular

Sztuk w opakowaniu:

10 x 1 mL

Typ recepty:

(S1) This Schedule is intentionally blank

Wskazania:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Podsumowanie produktu:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Status autoryzacji:

Licence status A

Data autoryzacji:

2007-07-16